Litigation Details for TAKEDA PHARMACEUTICAL COMPANY LIMITED v. NORWICH PHARMACEUTICALS, INC. (D.N.J. 2020)
✉ Email this page to a colleague
TAKEDA PHARMACEUTICAL COMPANY LIMITED v. NORWICH PHARMACEUTICALS, INC. (D.N.J. 2020)
| Docket | ⤷ Sign Up | Date Filed | 2020-07-15 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | Referred To | Cathy L. Waldor | |
| Patents | 7,105,486; 7,223,735; 7,655,630; 7,659,253; 7,659,254; 7,662,787; 7,662,788; 7,671,030; 7,671,031; 7,674,774; 7,678,770; 7,678,771; 7,687,466; 7,687,467; 7,700,561; 7,713,936; 7,718,619; 7,723,305 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in TAKEDA PHARMACEUTICAL COMPANY LIMITED v. NORWICH PHARMACEUTICALS, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for TAKEDA PHARMACEUTICAL COMPANY LIMITED v. NORWICH PHARMACEUTICALS, INC. (D.N.J. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2022-03-02 | 173 | Order AND Opinion | The patents are: U.S. Patent Nos. 7,105,486 (“the ’486 patent”), 7,223,735 (“the ’735 patent”), 7,…7,655,630 (“the ’630 patent”), 7,659,253 (“the ’253 patent”), No. 7,659,254 (“the ’254 patent”), 7,662,787 …7,662,787 (“the ’787 patent”), 7,662,788 (“the ’788 patent”), 7,671,030 (“the ’030 patent”), 7,671,031 (“the…the ’031 patent”), 7,674,774 (“the ’774 patent”), 7,678,770 (“the ’770 patent”), 7,678,771 (“the ’771…PageID: 51081 patent”), 7,687,467 (“the ’467 patent”), 7,700,561 (“the ’561 patent”), 7,713,936 (“the | External link to document |
| 2022-10-13 | 400 | Order on Motion for Summary Judgment AND Order on Motion to Preclude | . 7,105,486 (“the ’486 patent”), claim 5 of U.S. Patent No. 7,678,770, and claim 7 of U.S. Patent No…787 patent”), claim 14 of U.S. Patent No. 7,687,466 (“the ’466 patent”), claim 4 of U.S. Patent No.… 1 and 4 of U.S. Patent No. 7,655,630 (“the ’630 patent”), claim 2 of U.S. Patent No. 7,662,787 (“the…expiration of the ’735 patent would infringe claim 15 of the ’735 patent, if valid and enforceable…meets the limitation recited in claim 2 of the ’253 patent, (3) would have unit-cell parameters that | External link to document |
| 2022-12-26 | 483 | Opinion | U.S. Patent No. 7,687,466 (“the ’466 patent”), U.S. Patent No. 7,105,486 (“the ’486 patent”), U.S…filed on June 1, 2004, (now U.S. Patent No. 7,105,486), which is a continuation-in-part of Application… U.S. Patent No. 7,655,630 (“the ’630 patent”), U.S. Patent No. 7,662,787 (“the ’787 patent”), U.….S. Patent No. 7,678,770 (“the ’770 patent”), U.S. Patent No. 7,671,031 (“the ’031 patent”), U.S.…U.S. Patent No. 7,223,735 (“the ’735 patent”), U.S. Patent No. 7,700,561 (“the ’561 patent”), and | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
